Outsourcing

Apr 17, 2018
By BioPharm International Editors
The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.
Apr 16, 2018
By BioPharm International Editors
A new report gives an overview of the work of the International API Inspection Program.
Apr 13, 2018
By BioPharm International Editors
A $5.5-million expansion at its Philadelphia, PA clinical supplies facility gives Catalent additional packaging and storage capacity.
Apr 11, 2018
By BioPharm International Editors
A new study by the Business Research Company reveals prominent contract research organization outsourcing trends.
Apr 11, 2018
By BioPharm International Editors
FDA sent a warning letter to Tris Pharma Inc. after investigators found the company had failed to properly investigate batch failures and establish quality control procedures.
Apr 10, 2018
By BioPharm International Editors
The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.
Apr 06, 2018
By BioPharm International Editors
On Tuesday, April 24, 2018, Evan Boswell, senior principal scientist at Pfizer CentreOne Contract Manufacturing, Pfizer CentreOne will give a presentation on scaling up the manufacturing process of active pharmaceutical ingredients at CPhI North America in Philadelphia, PA.
Apr 06, 2018
By BioPharm International Editors
The contract manufacturing organization’s facility in Boulder, CO, has passed general inspection from FDA.
Apr 05, 2018
By BioPharm International Editors
The contract service provider will invest in a laboratory expansion at its site located in Tredegar, Wales, UK.
Apr 05, 2018
By BioPharm International Editors
The active pharmaceutical ingredient and excipient provider has expanded its parenteral ingredient manufacturing capacity and lab services.
native1_300x100
lorem ipsum